About this trial
The goal of this prospective observational study is to describe the incidence of reverse trigger (RT) in mechanically ventilated patients with diagnosis of acute respiratory distress syndrome (ARDS).
The main questions it aims to answer are:
* Real incidence of RT based on continuous monitoring * The response to mechanical ventilatiory adjustments Participants will be included as soon as neuromuscular blockers (NMB)/sedation is stopped or in case of spontaneous respiratory efforts detection, whatever happens first. Continuous monitoring will be performed by esophageal manometry until switch to a pressure support (spontaneous) mode, restart of deep sedation/neuromuscular blockers by medical indication, or death.
In order to allow detection of possible RT in patients with ongoing sedation/NMB, mechanical ventilator waveforms will be screened every 1-2 hours by investigators and critical care physicians with at least 1 year of specific training in detection of dyssynchronies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of ARDS according to the Berlin criteria and added New Global Definition 2023
Mechanical ventilation
Disqualifiers
<18 years
Tracheostomy status
Pneumothorax
Tube thoracostomy with air leaks
Trial population
Mechanically ventilated patients with acute respiratory distress syndrome.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Incidence of reverse trigger
Proportion of patients who developed reverse trigger
Secondary outcomes
Days of mechanical ventilation
Days of mechanical ventilation
ICU length of stay
Days from ICU admission to discharge to wards
Mortality
Rate of deceased patients in percentage
Other outcomes
Duration of RT
Total time of presence of RT
Phenotypes of RT
Rate of the different phenotypes according to cycle initiation and termination of patient's respiratory effort
Intensity of breathing efforts
Intensity of respiratory efforts as measured by esophageal manometry
Association with severity
Association of RT with lung disease severity as measured by pO2:FiO2 ratio
Sponsors and contacts
Click on the lead sponsor to view all of their trials.